NewsRx

Search our medical news database

Bioscience

Epiphany Biosciences Announces Appointments to Its Board of Directors

Published in Healthcare Mergers, Acquisitions and Ventures Week, April 21st, 2007

Epiphany Biosciences, Inc. announced six appointments to its board of directors. The directors include Charles Sanders, MD, former Chairman and CEO of Glaxo, Inc.; Clyde T. Turner, Chairman and CEO of Global Trust Ventures, LLC; John Quelch, DBA, MBA, MS, Senior Associate Dean and Lincoln Filene Professor of Business Administration at Harvard Business School; Paul A. Mieyal, PhD, CFA, Vice President of Wexford Capital LLC; Lee Meisel, MD, MPH, JD, President of Windsor Bay Capital; and Fred Volinsky, MD, Epiphany's CEO, who will also serve as Chairman of the board. A seventh board seat remains to be filled.

"We are thrilled to have assembled a board with such superlative...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook